ARCHIVES

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

This article is from The Cancer Letter archive.

Vol. 13 No. 16 | April 17, 1987

Download PDF Visit The Full Archive

Related Articles

Clinical Research PA In Lung Cancer Is Released

August 16, 1991

Tracors’ Prime Contract Includes $1 Million for Additional Tests

May 17, 1974

Task Force Issues Guidless on LDCT Lung Screening

January 10, 2014

Oxandrolone And Education Improves Weight Gain

February 28, 2003

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

June 20, 2014

Schmidt Attempted To Answer Critics

October 1, 1976